Compendium of Cancer Genome Aberrations

FEMA5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."
 
No edit summary
 
(12 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>
Line 17: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|
==== CHAPTER 2 (TUMOURS OF THE OVARY) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_borderline_tumour_of_the_ovary|Serous borderline tumour of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Low-grade_serous_carcinoma_of_the_ovary|Low-grade serous carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:High-grade_serous_carcinoma_of_the_ovary|High-grade serous carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_cystadenoma_and_adenofibroma|Mucinous cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_borderline_tumour_|Mucinous borderline tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_carcinoma_of_the_ovary|Mucinous carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_cystadenoma_and_adenofibroma|Endometrioid cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_borderline_tumour|Endometrioid borderline tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_ovary|Endometrioid carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Clear_cell_cystadenoma_and_adenofibroma|Clear cell cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Clear_cell_borderline_tumour|Clear cell borderline tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Clear_cell_carcinoma_of_the_ovary|Clear cell carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Seromucinous_cystadenoma_and_adenofibroma|Seromucinous cystadenoma and adenofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Seromucinous_borderline_tumour|Seromucinous borderline tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Brenner_tumour_|Brenner tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Borderline_Brenner_tumour|Borderline Brenner tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Malignant_Brenner_tumour_|Malignant Brenner tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mesonephric-like_adenocarcinoma|Mesonephric-like adenocarcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_ovary|Undifferentiated and dedifferentiated carcinomas of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_ovary|Carcinosarcoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_carcinoma_of_the_ovary|Mixed carcinoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_ovary|Endometrioid stromal sarcoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Smooth_muscle_tumours_of_the_ovary|Smooth muscle tumours of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ovarian_myxoma_|Ovarian myxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_ovary|Adenosarcoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ovarian_fibroma_|Ovarian fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Thecoma_|Thecoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Luteinized_thecoma_associated_with_sclerosing_peritonitis_|Luteinized thecoma associated with sclerosing peritonitis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Sclerosing_stromal_tumour_|Sclerosing stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Microcystic_stromal_tumour_|Microcystic stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Signet-ring_stromal_tumour_|Signet-ring stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leydig_cell_tumour_|Leydig cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Steroid_cell_tumour_|Steroid cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ovarian_fibrosarcoma_|Ovarian fibrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adult_granulosa_cell_tumour_|Adult granulosa cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Juvenile_granulosa_cell_tumour_|Juvenile granulosa cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Sertoli_cell_tumour_|Sertoli cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Sex_cord-stromal_tumour_NOS|Sex cord-stromal tumour NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Gynandroblastoma|Gynandroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mature_teratoma_of_the_ovary|Mature teratoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Immature_teratoma_of_the_ovary|Immature teratoma of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Dysgerminoma_|Dysgerminoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Yolk_sac_tumour_|Yolk sac tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Embryonal_carcinoma_|Embryonal carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Non-gestational_choriocarcinoma_|Non-gestational choriocarcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_germ_cell_tumour_of_the_ovary|Mixed germ cell tumour of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Struma_ovarii_|Struma ovarii]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ovarian_carcinoid|Ovarian carcinoid]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Neuroectodermal-type_tumours|Neuroectodermal-type tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Monodermal_cystic_teratoma_|Monodermal cystic teratoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Somatic_neoplasms_arising_from_teratomas|Somatic neoplasms arising from teratomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Gonadoblastoma|Gonadoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_germ_cell-sex_cord-stromal_tumour,_unclassified|Mixed germ cell-sex cord-stromal tumour, unclassified]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Rete_cystadenoma,_adenoma,_and_adenocarcinoma|Rete cystadenoma, adenoma, and adenocarcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Wolffian_tumour_of_the_ovary|Wolffian tumour of the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Solid_pseudopapillary_tumour_|Solid pseudopapillary tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Wilms_tumour_|Wilms tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Follicle_cyst|Follicle cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Corpus_luteum_cyst|Corpus luteum cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Large_solitary_luteinized_follicle_cyst|Large solitary luteinized follicle cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Hyperreactio_luteinalis|Hyperreactio luteinalis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Pregnancy_luteoma|Pregnancy luteoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Stromal_hyperplasia_and_hyperthecosis|Stromal hyperplasia and hyperthecosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Fibromatosis_and_massive_oedema|Fibromatosis and massive oedema]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leydig_cell_hyperplasia|Leydig cell hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Metastases_to_the_ovary|Metastases to the ovary]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Well-differentiated_papillary_mesothelial_tumour_|Well-differentiated papillary mesothelial tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:_Mesothelioma_| Mesothelioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_borderline_tumour_of_the_peritoneum|Serous borderline tumour of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Low-grade_serous_carcinoma_of_the_peritoneum|Low-grade serous carcinoma of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:High-grade_serous_carcinoma_of_the_peritoneum|High-grade serous carcinoma of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:_Leiomyomatosis_peritonealis_disseminata_| Leiomyomatosis peritonealis disseminata]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Calcifying_fibrous_tumour_|Calcifying fibrous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Extragastrointestinal_stromal_tumour|Extragastrointestinal stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Solitary_fibrous_tumour_of_the_peritoneum|Solitary fibrous tumour of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_stromal_sarcoma_of_the_peritoneum|Endometrioid stromal sarcoma of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mesothelial_hyperplasia|Mesothelial hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Transitional_cell_metaplasia|Transitional cell metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endosalpingiosis_of_the_peritoneum|Endosalpingiosis of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Histiocytic_nodule|Histiocytic nodule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ectopic_decidua|Ectopic decidua]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Splenosis|Splenosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other_tumour-like_lesions_of_the_peritoneum|Other tumour-like lesions of the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinomas_and_sarcomas_metastatic_to_the_peritoneum|Carcinomas and sarcomas metastatic to the peritoneum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Pseudomyxoma_peritonei|Pseudomyxoma peritonei]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Gliomatosis|Gliomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_fallopian_tube|Endometrioid carcinoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_fallopian_tube|Carcinosarcoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Paratubal_cysts|Paratubal cysts]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tubal_hyperplasia|Tubal hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Tubo-ovarian_abscess|Tubo-ovarian abscess]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Salpingitis_isthmica_nodosa|Salpingitis isthmica nodosa]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Metaplastic_papillary_lesion|Metaplastic papillary lesion]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Placental_site_nodule_occurring_in_the_fallopian_tube|Placental site nodule occurring in the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_metaplasia|Mucinous metaplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_fallopian_tube|Adenosarcoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Teratoma_of_the_fallopian_tube|Teratoma of the fallopian tube]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenomyoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenosarcoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyosarcoma of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Wolffian_tumour_of_the_broad_ligament_and_other_uterine_ligaments|Wolffian tumour of the broad ligament and other uterine ligaments]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Papillary_cystadenoma_|Papillary cystadenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ependymoma_|Ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adrenocortical_remnants|Adrenocortical remnants]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrial_atypical_hyperplasia_/_endometrioid_intraepithelial_neoplasia|Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_uterine_corpus|Endometrioid carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[FEMA5:Serous_carcinoma_of_the_uterine_corpus|Serous carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
Line 27: Line 1,476:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Clear_cell_carcinoma_of_the_uterine_corpus_|Clear cell carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
Line 36: Line 1,487:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_uterine_corpus|Undifferentiated and dedifferentiated carcinomas of the uterine corpus]]
|Disease
|
|
|
|
|
Line 45: Line 1,498:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mixed_carcinoma_of_the_uterine_corpus|Mixed carcinoma of the uterine corpus]]
|Disease
|
|
|
|
|
Line 54: Line 1,509:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Other_endometrial_carcinomas|Other endometrial carcinomas]]
|Disease
|
|
|
|
|
Line 63: Line 1,520:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Carcinosarcoma_of_the_uterine_corpus|Carcinosarcoma of the uterine corpus]]
|Disease
|
|
|
|
|
Line 72: Line 1,531:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrial_polyp|Endometrial polyp]]
|Disease
|
|
|
|
|
Line 81: Line 1,542:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrial_metaplasia|Endometrial metaplasia]]
|Disease
|
|
|
|
|
Line 90: Line 1,553:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_corpus|Arias-Stella reaction of the uterine corpus]]
|Disease
|
|
|
|
|
Line 99: Line 1,564:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Uterine_leiomyoma|Uterine leiomyoma]]
|Disease
|
|
|
|
|
Line 108: Line 1,575:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Intravenous_leiomyomatosis_|Intravenous leiomyomatosis]]
|Disease
|
|
|
|
|
Line 117: Line 1,586:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_uterine_corpus|Smooth muscle tumour of uncertain malignant potential of the uterine corpus]]
|Disease
|
|
|
|
|
Line 126: Line 1,597:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Metastasizing_leiomyoma_|Metastasizing leiomyoma]]
|Disease
|
|
|
|
|
Line 135: Line 1,608:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Uterine_leiomyosarcoma_|Uterine leiomyosarcoma]]
|Disease
|
|
|
|
|
Line 144: Line 1,619:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endometrial_stromal_nodule_|Endometrial stromal nodule]]
|Disease
|
|
|
|
|
Line 153: Line 1,630:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Low-grade_endometrial_stromal_sarcoma_|Low-grade endometrial stromal sarcoma]]
|Disease
|
|
|
|
|
Line 162: Line 1,641:
|
|
|-
|-
| ||Disease||
|[[FEMA5:High-grade_endometrial_stromal_sarcoma_|High-grade endometrial stromal sarcoma]]
|Disease
|
|
|
|
|
Line 171: Line 1,652:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Undifferentiated_uterine_sarcoma_|Undifferentiated uterine sarcoma]]
|Disease
|
|
|
|
|
Line 180: Line 1,663:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Uterine_tumour_resembling_ovarian_sex_cord_tumour_|Uterine tumour resembling ovarian sex cord tumour]]
|Disease
|
|
|
|
|
Line 189: Line 1,674:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Perivascular_epithelioid_cell_tumour_(PEComa)|Perivascular epithelioid cell tumour (PEComa)]]
|Disease
|
|
|
|
|
Line 198: Line 1,685:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
|
Line 207: Line 1,696:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenomyoma_of_the_uterine_corpus|Adenomyoma of the uterine corpus]]
|Disease
|
|
|
|
|
Line 216: Line 1,707:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Atypical_polypoid_adenomyoma_|Atypical polypoid adenomyoma]]
|Disease
|
|
|
|
|
Line 225: Line 1,718:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenosarcoma_of_the_uterine_corpus|Adenosarcoma of the uterine corpus]]
|Disease
|
|
|
|
|
Line 234: Line 1,729:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Central_primitive_neuroectodermal_tumour_/_CNS_embryonal_tumour|Central primitive neuroectodermal tumour / CNS embryonal tumour]]
|Disease
|
|
|
|
|
Line 243: Line 1,740:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Germ_cell_tumours_of_the_uterine_corpus|Germ cell tumours of the uterine corpus]]
|Disease
|
|
|
|
|
Line 252: Line 1,751:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ====
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
| ||Disease||
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
|Disease
|
|
|
|
|
Line 270: Line 1,783:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]]
|Disease
|
|
|
|
|
Line 279: Line 1,794:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Abnormal_(non-molar)_villous_lesions|Abnormal (non-molar) villous lesions]]
|Disease
|
|
|
|
|
Line 288: Line 1,805:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Partial_hydatidiform_mole|Partial hydatidiform mole]]
|Disease
|
|
|
|
|
Line 297: Line 1,816:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Complete_hydatidiform_mole|Complete hydatidiform mole]]
|Disease
|
|
|
|
|
Line 306: Line 1,827:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Invasive_and_metastatic_hydatidiform_moles|Invasive and metastatic hydatidiform moles]]
|Disease
|
|
|
|
|
Line 315: Line 1,838:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Epithelioid_trophoblastic_tumour_|Epithelioid trophoblastic tumour]]
|Disease
|
|
|
|
|
Line 324: Line 1,849:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Placental_site_trophoblastic_tumour_|Placental site trophoblastic tumour]]
|Disease
|
|
|
|
|
Line 333: Line 1,860:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Gestational_choriocarcinoma|Gestational choriocarcinoma]]
|Disease
|
|
|
|
|
Line 342: Line 1,871:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mixed_trophoblastic_tumour|Mixed trophoblastic tumour]]
|Disease
|
|
|
|
|
Line 351: Line 1,882:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ====
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
| ||Disease||
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
|Disease
|
|
|
|
|
Line 369: Line 1,914:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Atrophy_of_the_uterine_cervix|Atrophy of the uterine cervix]]
|Disease
|
|
|
|
|
Line 378: Line 1,925:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_uterine_cervix|Squamous intraepithelial lesions of the uterine cervix]]
|Disease
|
|
|
|
|
Line 387: Line 1,936:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-associated, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 396: Line 1,947:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-independent, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 405: Line 1,958:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endocervical_polyp|Endocervical polyp]]
|Disease
|
|
|
|
|
Line 414: Line 1,969:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mullerian_papilloma_of_the_uterine_cervix|Mullerian papilloma of the uterine cervix]]
|Disease
|
|
|
|
|
Line 423: Line 1,980:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Nabothian_cyst|Nabothian cyst]]
|Disease
|
|
|
|
|
Line 432: Line 1,991:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Tunnel_clusters|Tunnel clusters]]
|Disease
|
|
|
|
|
Line 441: Line 2,002:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Microglandular_hyperplasia|Microglandular hyperplasia]]
|Disease
|
|
|
|
|
Line 450: Line 2,013:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Lobular_endocervical_glandular_hyperplasia|Lobular endocervical glandular hyperplasia]]
|Disease
|
|
|
|
|
Line 459: Line 2,024:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Diffuse_laminar_endocervical_hyperplasia|Diffuse laminar endocervical hyperplasia]]
|Disease
|
|
|
|
|
Line 468: Line 2,035:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]]
|Disease
|
|
|
|
|
Line 477: Line 2,046:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Arias-Stella_reaction_of_the_uterine_cervix|Arias-Stella reaction of the uterine cervix]]
|Disease
|
|
|
|
|
Line 486: Line 2,057:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endocervicosis_of_the_uterine_cervix|Endocervicosis of the uterine cervix]]
|Disease
|
|
|
|
|
Line 495: Line 2,068:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Tuboendometrioid_metaplasia|Tuboendometrioid metaplasia]]
|Disease
|
|
|
|
|
Line 504: Line 2,079:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Ectopic_prostate_tissue|Ectopic prostate tissue]]
|Disease
|
|
|
|
|
Line 513: Line 2,090:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-associated, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 522: Line 2,101:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma, HPV-associated, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 531: Line 2,112:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenocarcinoma_in_situ,_HPV-independent,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-independent, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 540: Line 2,123:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenocarcinoma,_HPV-independent,_gastric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 549: Line 2,134:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenocarcinoma,_HPV-independent,_clear_cell_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 558: Line 2,145:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenocarcinoma,_HPV-independent,_mesonephric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, mesonephric type, of the uterine cervix]]
|Disease
|
|
|
|
|
Line 567: Line 2,156:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Other_adenocarcinomas_of_the_uterine_cervix|Other adenocarcinomas of the uterine cervix]]
|Disease
|
|
|
|
|
Line 576: Line 2,167:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Carcinosarcoma_of_the_uterine_cervix|Carcinosarcoma of the uterine cervix]]
|Disease
|
|
|
|
|
Line 585: Line 2,178:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenosquamous_and_mucoepidermoid_carcinomas_of_the_uterine_cervix|Adenosquamous and mucoepidermoid carcinomas of the uterine cervix]]
|Disease
|
|
|
|
|
Line 594: Line 2,189:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenoid_basal_carcinoma_of_the_uterine_cervix|Adenoid basal carcinoma of the uterine cervix]]
|Disease
|
|
|
|
|
Line 603: Line 2,200:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Carcinoma_of_the_uterine_cervix,_unclassifiable|Carcinoma of the uterine cervix, unclassifiable]]
|Disease
|
|
|
|
|
Line 612: Line 2,211:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenomyoma_of_the_uterine_cervix|Adenomyoma of the uterine cervix]]
|Disease
|
|
|
|
|
Line 621: Line 2,222:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Adenosarcoma_of_the_uterine_cervix|Adenosarcoma of the uterine cervix]]
|Disease
|
|
|
|
|
Line 630: Line 2,233:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Germ_cell_tumours_of_the_uterine_cervix|Germ cell tumours of the uterine cervix]]
|Disease
|
|
|
|
|
Line 639: Line 2,244:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 10 (TUMOURS OF THE VAGINA) ====
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
| ||Disease||
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
|Disease
|
|
|
|
|
Line 657: Line 2,276:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Atrophy_of_the_vagina|Atrophy of the vagina]]
|Disease
|
|
|
|
|
Line 666: Line 2,287:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Tubulosquamous_polyp_|Tubulosquamous polyp]]
|Disease
|
|
|
|
|
Line 675: Line 2,298:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Squamous_intraepithelial_lesions_of_the_vagina|Squamous intraepithelial lesions of the vagina]]
|Disease
|
|
|
|
|
Line 684: Line 2,309:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vagina|Squamous cell carcinoma, HPV-associated, of the vagina]]
|Disease
|
|
|
|
|
Line 693: Line 2,320:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vagina|Squamous cell carcinoma, HPV-independent, of the vagina]]
|Disease
|
|
|
|
|
Line 702: Line 2,331:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Villous_adenoma_|Villous adenoma]]
|Disease
|
|
|
|
|
Line 711: Line 2,342:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Mullerian_papilloma_of_the_vagina|Mullerian papilloma of the vagina]]
|Disease
|
|
|
|
|
Line 720: Line 2,353:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Vaginal_adenosis|Vaginal adenosis]]
|Disease
|
|
|
|
|
Line 729: Line 2,364:
|
|
|-
|-
| ||Disease||
|[[FEMA5:Endocervicosis_of_the_vagina|Endocervicosis of the vagina]]
|Disease
|
|
|
|
|
Line 738: Line 2,375:
|
|
|-
|-
|[[FEMA5:Cysts_of_the_vagina|Cysts of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_vagina|Adenocarcinoma, HPV-associated, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Endometrioid_carcinoma_of_the_vagina|Endometrioid carcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Clear_cell_carcinoma_of_the_vagina|Clear cell carcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_carcinoma,_gastric_type,_of_the_vagina|Mucinous carcinoma, gastric type, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucinous_carcinoma,_intestinal_type,_of_the_vagina|Mucinous carcinoma, intestinal type, of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mesonephric_adenocarcinoma_of_the_vagina|Mesonephric adenocarcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinosarcoma_of_the_vagina|Carcinosarcoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mixed_tumour_of_the_vagina|Mixed tumour of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_of_Skene_gland_origin_|Adenocarcinoma of Skene gland origin]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosquamous_carcinoma_of_the_vagina|Adenosquamous carcinoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenosarcoma_of_the_vagina_|Adenosarcoma of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Germ_cell_tumours_of_the_vagina|Germ cell tumours of the vagina]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 11 (TUMOURS OF THE VULVA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Vulvar_intraepithelial_neoplasia,_HPV-independent|Vulvar intraepithelial neoplasia, HPV-independent]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vulva|Squamous cell carcinoma, HPV-associated, of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vulva|Squamous cell carcinoma, HPV-independent, of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Papillary_hidradenoma_|Papillary hidradenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Chondroid_syringoma|Chondroid syringoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Fibroadenoma_|Fibroadenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Phyllodes_tumour|Phyllodes tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_of_mammary_gland_type_|Adenocarcinoma of mammary gland type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Bartholin_gland_cyst|Bartholin gland cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Bartholin_gland_hyperplasia,_adenoma,_and_adenomyoma|Bartholin gland hyperplasia, adenoma, and adenomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Bartholin_gland_carcinomas|Bartholin gland carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other_cysts_of_the_vulva|Other cysts of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Paget_disease_|Paget disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinomas_of_sweat_gland_origin|Carcinomas of sweat gland origin]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Adenocarcinoma_of_intestinal_type_|Adenocarcinoma of intestinal type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Germ_cell_tumours_of_the_vulva|Germ cell tumours of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Carcinoma_admixed_with_neuroendocrine_carcinoma_|Carcinoma admixed with neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Follicular_lymphoma|Follicular lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Burkitt_lymphoma|Burkitt lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Myeloid_sarcoma|Myeloid sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Lipoma_|Lipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Liposarcoma_|Liposarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Postoperative_spindle_cell_nodule|Postoperative spindle cell nodule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Fibroepithelial_stromal_polyp|Fibroepithelial stromal polyp]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Prepubertal_fibroma|Prepubertal fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Superficial_myofibroblastoma_|Superficial myofibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Myofibroblastoma_|Myofibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Cellular_angiofibroma_|Cellular angiofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Angiomyofibroblastoma_|Angiomyofibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Solitary_fibrous_tumour_of_the_lower_genital_tract|Solitary fibrous tumour of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Dermatofibrosarcoma_protuberans_|Dermatofibrosarcoma protuberans]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Kaposi_sarcoma_|Kaposi sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Angiosarcoma_|Angiosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyoma_of_the_lower_genital_tract|Leiomyoma of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_lower_genital_tract|Smooth muscle tumour of uncertain malignant potential of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Leiomyosarcoma_of_the_lower_genital_tract|Leiomyosarcoma of the lower genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Rhabdomyoma_|Rhabdomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Benign_peripheral_nerve_sheath_tumours|Benign peripheral nerve sheath tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Granular_cell_tumour_|Granular cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Superficial_angiomyxoma_|Superficial angiomyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Deep_(aggressive)_angiomyxoma_|Deep (aggressive) angiomyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Epithelioid_sarcoma_|Epithelioid sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Alveolar_soft_part_sarcoma_|Alveolar soft part sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Ewing_sarcoma_|Ewing sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 15 (MELANOCYTIC LESIONS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Blue_naevus_|Blue naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 16 (METASTASIS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Lynch_syndrome|Lynch syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[FEMA5:Other genetic tumour syndromes of the female genital tract|Other genetic tumour syndromes of the female genital tract]]
|Disease
|Disease
|
|
Retrieved from "https://test.ccga.io/index.php/FEMA5:Volunteer_Assignments_and_Opportunities"